alexa A New Perspective On Estrogen Receptor Beta In Ovarian Cancer Progression
ISSN: 2161-1017

Endocrinology & Metabolic Syndrome
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Endocrinology
October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Daniela Gallo
Accepted Abstracts: Endocrinol Metab Synd
DOI: 10.4172/2161-1017.S1.007
Abstract
Of the gynecological malignancies, epithelial ovarian cancer is the leading cause of death in the great majority of developed countries with more than 140,000 women dying from this cancer across the world in 2008. The importance of estrogen signaling in the development and progression of ovarian cancer has been assumed to be less significant than in breast or endometrial malignancies, although preclinical studies and clinical data have shown that not only normal ovaries but also many malignant ovarian tumors can be considered as endocrine related, and hormone-dependent. Estrogens exert their action through two estrogen receptors (ERα and ERβ) that are encoded by separate genes. In the healthy ovary, the levels of ERβ are high and predominate over ERα, being ERβ1, -β2, and -β5 the most represented isoforms. The majority of ovarian tumors also express ERβ, but few studies have examined the prognostic role of ERβ isoforms in ovarian cancer. We have recently shown a strong statistical association of cytoplasmic ERβ2 immunoreactivity with an unfavorable outcome in advanced serous ovarian cancer patients, a finding also reported in familial and sporadic breast cancer. The functional role of cytoplasmic ERβ2 is far from being elucidated, however preliminary data from our ongoing studies suggest that cytoplasmic protein accumulation may confer pro-survival advantages to ovarian cancer cells by inhibiting apoptotic pathways.
Biography
Daniela Gallo completed her first Master?s Degree in Pharmaceutical Chemistry & Technology in 1990, her second in Pharmacy in 1992, and her PhD in Pharmacology and Toxicology in 1998, at the University La Sapienza of Rome. She is currently responsible for the Pre-Clinical Oncology Unit at the Department of Obstetrics and Gynecology, Catholic University Medical School in Rome. She also actively participates to the preparation of clinical trials in the field of Gynecologic Oncology. She is a Lecturer for the post graduate course in ?Preclinical and clinical drug development: technical, regulatory and ethical aspects? at the Catholic University Medical School in Rome. She has published more than 45 papers in peer-reviewed journals.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords